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Abstract: Colonic diverticulosis is a very common condition. Many patients develop diverticulitis or
other complications of diverticular disease. Recent genome-wide association studies (GWAS) consis-
tently identified three major genetic susceptibility factors for both conditions, but did not discriminate
diverticulititis and diverticulosis in particular due the limitations of registry-based approaches. Here,
we aimed to confirm the role of the identified variants for diverticulosis and diverticulitis, respectively,
within a well-phenotyped cohort of patients who underwent colonoscopy. Risk variants rs4662344 in
Rho GTPase-activating protein 15 (ARHGAP15), rs7609897 in collagen-like tail subunit of asymmetric
acetylcholinesterase (COLQ) and rs67153654 in family with sequence similarity 155 A (FAM155A) were
genotyped in 1,332 patients. Diverticulosis was assessed by colonoscopy, and diverticulitis by imaging,
clinical symptoms and inflammatory markers. Risk of diverticulosis and diverticulitis was analyzed in
regression models adjusted for cofactors. Overall, the variant in FAM155A was associated with diverti-
culitis, but not diverticulosis, when controlling for age, BMI, alcohol consumption, and smoking status
(ORadjusted 0.49 [95% CI 0.27-0.89], p = 0.002). Our results contribute to the assessment specific genetic
variants identified in GWAS in the predisposition to the development of diverticulitis in patients with
diverticulosis.
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Common variation in FAM155A is 
associated with diverticulitis but 
not diverticulosis
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Frank Grünhage1, Beate Appenrodt1, Vincent Zimmer1, Algimantas Tamelis7, 
Jaune I. Lukosiene2, Neringa Pauziene8, Gediminas Kiudelis2, Laimas Jonaitis2, 
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Colonic diverticulosis is a very common condition. Many patients develop diverticulitis or other 
complications of diverticular disease. Recent genome-wide association studies (GWAS) consistently 
identified three major genetic susceptibility factors for both conditions, but did not discriminate 
diverticulititis and diverticulosis in particular due the limitations of registry-based approaches. Here, 
we aimed to confirm the role of the identified variants for diverticulosis and diverticulitis, respectively, 
within a well-phenotyped cohort of patients who underwent colonoscopy. Risk variants rs4662344 in 
Rho GTPase-activating protein 15 (ARHGAP15), rs7609897 in collagen-like tail subunit of asymmetric 
acetylcholinesterase (COLQ) and rs67153654 in family with sequence similarity 155 A (FAM155A) were 
genotyped in 1,332 patients. Diverticulosis was assessed by colonoscopy, and diverticulitis by imaging, 
clinical symptoms and inflammatory markers. Risk of diverticulosis and diverticulitis was analyzed 
in regression models adjusted for cofactors. Overall, the variant in FAM155A was associated with 
diverticulitis, but not diverticulosis, when controlling for age, BMI, alcohol consumption, and smoking 
status (ORadjusted 0.49 [95% CI 0.27–0.89], p = 0.002). Our results contribute to the assessment specific 
genetic variants identified in GWAS in the predisposition to the development of diverticulitis in patients 
with diverticulosis.
Colonic diverticulosis is a widespread gastrointestinal condition described as formation of diverticula, which are 
sac-like protrusions of mucosa and submucosa through muscularis externa1,2. Although diverticulosis is predom-
inantly asymptomatic, many patients develop symptoms3,4. These manifestations are classified as uncomplicated 
and complicated diverticular disease (DD), an inflammation of the tissue (diverticulitis) or diverticular bleed-
ing. The prevalence of the disease and its complications is constantly increasing due to the aging populations5,6. 
Therefore, the identification of underlying pathobiological mechanisms of the disease is relevant for improving 
everyday clinical practice. It is hypothesized that environmental factors together with structural alteration of the 
colonic wall and remodeling of the enteric nervous system are all predisposing components in the development 
of colonic diverticula5. In recent years, epidemiological twin data have suggested that genetic factors are another 
major cofactor in the pathogenesis of DD7,8. Up to date, there has been relatively little research effort to determine 
these genes and their sequence variants that are associated with the development of DD9. Recently an Icelandic 
study group published a genome-wide association study (GWAS) searching for sequence variants that affect the 
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risk of developing DD in the Icelandic population, containing a replication cohort of Danish individuals with 
DD10. The initial analysis included 15,220 Icelanders who were tested for associations with DD (5,426 cases) and 
its more severe form diverticulitis (2,764 cases). Subsequently, after applying weighted thresholds11, 16 sequence 
variants identified in the GWAS were followed up in a DD sample from Denmark with 5,970 cases and 3,020 
controls. In the combined analysis of these sample sets, three genetic loci that show genome wide-significance and 
may be associated with the risk of DD and/or diverticulitis were identified: intronic variants at the ARHGAP15 
(Rho GTPase-activating protein 15), COLQ (collagen-like tail subunit of asymmetric acetylcholinesterase) 
and FAM155A (family with sequence similarity 155 A) loci were significantly associated with DD. The second 
GWAS12 included 27,444 patients from the European component of the UK Biobank resource and compared 
them with 382,284 controls. Overall, 154 associated variants were further tested in 31,221 patients from the 
Michigan Genomics Initiative, finally confirming 42 associated variants including the three previously identified 
variants10. Most recently, a third european GWAS13 containing 451,099 patients in addition to identification of 
further loci, also confirmed these three major loci.
Notably, the dissection of the specific phenotypes diverticulosis and diverticulitis was incomplete in the 
GWAS, since the assessment of diverticulosis or diverticulitis is based on the ICD code. The studies applied 
the corresponding ICD codes in the ICD10 (K572-K579) and ICD9 (K562.10-13) systems, which also encom-
passes patients with diverticulitis (as well as diverticular bleeding), among the patients with diverticulosis. Even 
though ICD codes can identify patients with diverticulosis and DD, they do not discriminate between divertic-
ulosis and diverticulitis14. A subanalysis of the patients from the Icelandic subcohort of the Icelandic/Danish 
GWAS included only patients with either surgically treated or complicated diverticulitis10, whereas mild and 
often also outpatient-treated cases of diverticulitis were probably mostly missed. This information is not availa-
ble in the Danish subcohort at all. Additionally, patients with asymptomatic diverticulosis were not analyzed in 
these GWAS studies. A part of our samples were used in the GWAS from Schafmayer et al.13, and after adding 
further samples re-analyzed using additional clinical covariates from the database as outlined below and specifi-
cally focusing on patients with diverticulosis no prior diverticulitis as controls and (endpoint diverticulitis) and 
healthy with no diverticula (endpoint diverticulosis).
In this study, we therefore aimed to evaluate the associations between three major SNPs reported in the 
Icelandic GWAS applying weighted thresholds and confirmed in the North-American12 and European11,13 GWAS: 
ARHGAP15 (rs4662344), COLQ (rs7609897) and FAM155A (rs67153654). The risk of developing diverticulosis 
and diverticulitis, respectively, was determined in a Caucasian (german/lithuanian) cohort phenotypically char-
acterized for the specific phenotypes diverticulosis and diverticulitis. Due to the similar genetic background of 
Germans and Lithuanians15, a combined analysis was performed.
Patients and Methods
Study population. All patients taking part in the study were recruited at the Department of Medicine II, 
Saarland University Medical Center, Homburg, the Clinic for Gastroenterology and Hepatology, University 
Hospital of Cologne, Cologne, Germany, and the Department of Gastroenterology at the Lithuanian University 
of Health Sciences, Kaunas in Lithuania between 2012 and 2016 from patients referred for colonoscopy. A part 
of the samples from the Lithuanian cohorts came from our previous studies on colonic diseases and diverticu-
losis16–18 and were also used in a previous GWAS with less clinical information13. All patients and controls were 
of self-reported Caucasians ancestry (including grandparents). Risk factors, epidemiological and baseline data 
were assessed using a structured interview, performed by a physician assisting the patients with the question-
naires. The presence of diverticula was assessed by colonoscopy in all patients, which is the most widely accepted 
standard to detect diverticula. Only patients with complete colonoscopy including inspection of the cecum and 
at least adequate preparation, as assessed by the physician performing colonoscopy, were included in the study. 
All colonoscopies were performed using digital video endoscopes (high-resolution scopes Olympus CF 160, 180 
or 190) by a senior gastroenterologist. Intestinal lavage for endoscopic examination was performed using 2 liters 
of a solution containing polyethylene glycol. Patients with inherited connective tissue disorders such as Ehlers-
Danlos- or Marfan syndrome, non-Caucasian ethnicity or relatives of included patients were also excluded. The 
diagnosis of diverticulitis was established according to the current classifications for DD19,20. It was based on 
imaging by either computed tomography and/or ultrasound imaging as well corresponding clinical (pain in the 
lower left abdomen) and laboratory characteristics (increased serum inflammation markers). Suspected compli-
cated diverticulitis was assessed with computed tomography in all cases. The study protocol was approved by the 
Research Ethics Committee of the Saarland University (approval 63/11), the Research Ethics Committee of the 
University of Cologne (approval 16–397) and the Regional Kaunas Ethics Committee (protocol No BE-10-2). 
The study was performed according to the Declaration of Helsinki. All patients have signed an informed consent 
form to participate in the study. For the purpose of this study, cases were defined as patients with diverticulosis 
or diverticulitis, respectively.
DNA extraction and genotyping. Genomic DNA was extracted from peripheral blood mononuclear cells 
using the DNeasy Blood& Tissue Kit (Qiagen, Hilden, Germany). DNA concentrations were measured using 
a NanoDrop spectrophotometer. DNA samples were stored at −20 °C until analysis. Genotyping of the three 
genetic polymorphisms (rs4662344, rs7609897 and rs67153654) with Taqman assays was performed in 856 
patients with diverticulosis and 479 controls of Caucasian descent in our accredited laboratory (DIN EN ISO 
15189) in Homburg by a technician blinded to the phenotype of the patients. The fluorescence data was analyzed 
with allelic discrimination 7500 software v.2.0.6.
Statistical analysis. Statistical Package for the Social Sciences (SPSS, Version 20, IBM, Munich, Germany) 
was used for statistical analysis. Power calculations were performed using PS (http://biostat.mc.vanderbilt.edu/
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wiki/Main/PowerSampeSize) to detect a significantly increased OR of 2 with a power of 80%, based on the corre-
sponding frequencies of the risk alleles in rs4662344, rs7609897 and rs67153654, and assuming type I error rates 
of 0.05. Quantitative data were expressed as medians and ranges. Comparisons of frequencies of genotypes at the 
three loci were performed in 3 × 2 contingency tables listing cases and controls. Genotypic and allelic association 
tests were performed using χ2-square or Fisher’s exact tests (https://ihg.gsf.de/cgi-bin/hw/hwa1.pl). Due to the 
few homozygous mutants of the risk alleles we applied a dominant model. Genotype association analysis between 
SNPs and diverticulosis was performed using multiple logistic regression models adjusted for age, BMI, smok-
ing status, and alcohol consumption, assuming log-additive effects. P-values < 0.05 were considered statistically 
significant. Results are expressed as odds ratios (OR) and 95% confidence intervals (CI). Pairwise linkage dise-
quilibrium (r2) was calculated utilizing LDpair21 using a caucasian reference population (CEU) of the identified 
variants in all three GWAS10,12,13.
Results
Patient characteristics. In total, 1,332 patients (634 men, 47.6%) were included. Table 1 summarizes the 
baseline data of this study cohort. Frequency of diverticulosis in our cohort was similar to prior data20. The 
median age was 64 years (IQR 55–72). Characteristics of the subgroup of patients with diverticulitis are presented 
Parameter
Diverticulosis 
(n = 858) Controls (n = 474)
Diverticulitis 
(n = 198) Total (n = 1332) P value* P value**
Age, years 67 (59–74) 57 (46–66) 61 (53–71) 64 (55–72) <0.001 <0.001
BMI, kg/m2 27.9 (25.2–31.6) 26.7 (23.7–30.3) 27.1 (24.8–30.5) 27.5 (24.8–31.2) <0.001 0.20
Gender, men/women 424 (49.4%) 210 (44.3%) 105 (53.0%) 634 (47.6%) 0.08 0.26
Smoking ever, yes/no 300 (35.6%) 168 (36.7%) 86 (43.9%) 468 (36.0%) 0.72 0.006
Alcohol (daily), yes/no 50 (6.0%) 21 (4.6%) 19 (9.9%) 71 (5.5%) 0.31 0.01
Table 1. Baseline data of study population. Values are given as median and interquartillic range (IQR), 
or frequencies and percentages. BMI = body mass index; Significant P values are highlighted in bold. 
*Diverticulosis versus healthy controls, **Diverticulitis versus Diverticulosis with no prior diverticulitis.
Gene Amin/Amaj MAF (%) CT (%) TT (%) OR Ptrend OR (95% CI) Pallelic OR (95% CI) Pgenotypic
ARHGAP15 (rs4662344)
Diverticulitis* T/C 19.5 32.8 3.1 1.20 0.16 1.27 (0.91–1.76) 0.16 1.38 (0.67–2.84) 0.38
Diverticulosis** T/C 19.5 29.7 4.7 1.30 0.02 1.28 (1.00–1.63) 0.05 1.85 (0.97–3.50) 0.06
Controls(no diverticulosis) T/C 15.9 26.3 2.7
Controls(no prior diverticulitis) T/C 18.8 28.8 4.4
Iceland GWAS10Diverticular disease*** T/C 20.9 1.23 (1.17–1.29) <0.001
Iceland GWAS10Controls*** T/C 17.7
MGI GWAS12****Diverticular disease T/C 19.1/20.0 0.88/0.89 <0.001/0.07
MGI GWAS12****Controls T/C 17.3/18.0
European GWAS13Diverticular disease T/C 17.9****** <0.001
European GWAS14Controls T/C 17.9******
FAM155A (rs67153654) TA (%) AA (%)
Diverticulitis* A/T 14.1 21.9 3.1 0.68 0.01 0.66 (0.47–0.92) 0.01 0.45 (0.19–1.09) 0.07
Diverticulosis** A/T 22.8 35.4 5.1 1.01 0.90 1.01 (0.81–1.27) 0.91 1.02 (0.61–1.72) 0.93
Controls (no diverticulosis) A/T 22.6 35.2 5.1
Controls (no prior diverticulitis) A/T 24.3 37.1 5.8
Iceland GWAS10 Diverticular disease*** A/T 17.0 0.87 (0.83–0.91) <0.001
Iceland GWAS10 Controls*** A/T 18.6
MGI GWAS12*****Diverticular disease A/T 17.0/17.8 0.87/0.90 <0.001/0.024
MGI GWAS12*****Controls A/T 19.0/19.5
European GWAS13 Diverticular disease A/T 19.6******
European GWAS13 Controls A/T 19.6******
Table 2. Genotypic and allelic frequencies in ARHGAP15 and FAM155A of the combined German/Lithuanian 
cohort and published data from published GWAS. Genotypic and allelic frequencies of the variants. Values are 
given as count and percentage. Amaj = major allele; Amin = minor allele; CI = confidence interval; MAF minor 
allele frequency; MGI Michigan Genomics Initiative; OR = odds ratio. P Values calculated for *Diverticulitis 
versus Diverticulosis with no prior diverticulitis; **Diverticulosis versus healthy controls; ***refers to 
combined Icelandic/Danish sample; ****Data from variant rs6734367 which is in LD (r2 = 0.82) with variant 
rs4662344 in caucansians31, data from UK biobank/MGI; *****Data from the variant rs11619840 which is 
in LD (r2 = 0.93) with variant rs67153654 in caucansians31, data from UK biobank/MGI; ******Data only 
combined cases/controls available.
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in Supplementary Table 1. The call-rate for the variations were >95% for all variants. The genotype frequencies 
(cut-off P > 0.05) were in Hardy-Weinberg equilibrium (HWE) in all controls for the variants in ARHGAP15 and 
FAM155A. The HWE for the variant in COLQ deviated in controls (both in diverticulosis and diverticulitis-anal-
yses p < 0.001), and was not included in further analysis. The minor allele frequencies (MAF) (Table 2) were 
similar to prior data10,12,13. In comparison of patients with diverticulosis and controls, patients with diverticulosis 
were significantly (P < 0.001) older and more obese (P < 0.001) than individuals with no diverticulosis. When 
comparing patients with diverticulitis, with diverticulosis and no prior diverticulitis, patients with diverticulitis 
where significantly younger (P < 0.001), more often smokers (P = 0.006), and more frequently current alcohol 
drinkers (P = 0.001). No association was detected for BMI (P = 0.20) and gender (P = 0.26). Table 3 presents the 
data on linkage disequilibrium (LD) of all variants identified in the GWAS10,12,13.
Associations of variants and diverticulosis. Table 2 presents the allelic and genotypic frequencies com-
paring patients with diverticulosis to controls. MAF of the variant in ARHGAP15 (rs4662344) was increased 
compared to controls, as described in the GWAS10,12,13. The major (T) allele of rs4662344 in ARHGAP15 was 
significantly (OR 1.28; 95% CI 1.00–1.63) associated with diverticulosis. This association did not withstand after 
adjusting for corresponding environmental cofactors though (OR 1.22; 95% CI = 0.93–1.61) (Table 4). Neither 
was the MAF of the variant in rs67153654 in FAM155A different between cases and controls, nor could an asso-
ciation with diverticulosis be detected (Table 4).
Associations of SNPs and diverticulitis. The minor allele of the variant rs4662344 in ARHGAP15 
was more frequent in diverticulitis cases in comparison to controls with diverticulosis and no prior divertic-
ulitis, as similarly described previously in the GWAS10,12,13. The MAF of the major (A) allele of rs67153654 in 
FAM155A was markedly (OR 0.66; 95% CI 0.47–0.92) reduced in patients with prior diverticulitis compared to 
controls (Table 2) as also previously described10,12,13. These associations remained significant after adjusting for 
Variant present with 
significant association in 
GWAS (Reference number)
ARHGAP15 FAM155A
rs4662344 rs6734367 rs9520344 rs11619840 rs67153654 rs9555371 rs9520339
ARHGAP15
rs4662344 10,13 0.82 0.001 0.019 0.014 0.009 0.001
rs6734367 12,13 0.001 0.035 0.028 0.020 0.001
FAM155A
rs9520344 12,13 0.0021 0.0008 0.0043 1.0
rs11619840 12,13 0.93 0.83 0.0021
rs67153654 10,13 0.90 0.0008
rs9555371 13 0.0043
rs9520339 13
Table 3. Pairwise linkage disequilibrium (r2) calculated using LDpair (Machiela et al.31) with a caucasian 
reference population (CEU) of the identified variants in all three GWAS10,12,13. Bold values indicate where r2 is 
>0.8 representing strong LD. Variants from the initial GWAS10 are marked in underline.
Parameter Adjusted OR* (95% CI) P value
ARHGAP15 rs4662344:T (cc + tc vs tt) 1.22 (0.93–1.61) 0.15
ARHGAP15 rs4662344:TC (ct vs tt + cc) 1.14 (0.86–1.52) 0.35
ARHGAP15 rs4662344:TT (tt vs tc + cc) 1.89 (0.84–4.29) 0.13
FAM155A rs67153654:T (ta + aa vs tt) 1.09 (0.84–1.00) 0.53
FAM155A rs67153654:AT (ta vs tt + aa) 1.02 (0.78–1.30 0.89
FAM155A rs67153654:TT (tt vs at + aa) 1.19 (0.67–2.10) 0.56
Table 4. Multivariate analysis of factors associated with diverticulosis versus controls. CI = confidence interval. 
OR = odds ratio. *Adjusted for age, BMI, alcohol and smoking status.
Parameter Adjusted OR* (95% CI) P value
ARHGAP15 rs4662344:T (cc + tc vs tt) 1.43 (1.00–2.03) 0.05
ARHGAP15 rs4662344:TC (ct vs tt + cc) 1.35 (0.44–1.94) 0.11
ARHGAP15 rs4662344:TT (tt vs tc + cc) 1.40 (0.61–3.21) 0.43
FAM155A rs67153654:T (ta + aa vs tt) 0.70 (0.49–0.99) 0.04
FAM155A rs67153654:AT (ta vs tt + aa) 0.73 (0.51–1.06) 0.10
FAM155A rs67153654:TT (tt vs at + aa) 0.68 (0.27–1.69) 0.41
Table 5. Multivariate analysis of factors associated with diverticulitis in patients with diverticulosis. 
CI = confidence interval, OR = odds ratio. *Adjusted for age, BMI, alcohol and smoking status. Significant P 
values are highlighted in bold.
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environmental cofactors (Table 5). The variant rs4662344 in ARHGAP15 was borderline significantly (OR 1.43; 
95% CI 1.00–2.03; P = 0.05) associated with diverticulitis after adjusting for the corresponding cofactors. Even 
though hampered by small sample size, similar results (n = 64) were obtained when analyzing patients with sur-
gically treated diverticulitis (Supplementary Tables 2 and 3).
Discussion
The aim of our present study was to assess the role of genetic variations consistently identified in the three large 
recent GWAS10,12,13 for the specific risks for diverticulosis and diverticulitis, respectively. Our results are in line with 
previous data concerning the association of diverticulosis with age and BMI as risk factors (diverticulosis)22–24, 
as well as alcohol consumption25,26 and smoking status27–29 as risk factors for diverticulitis.
Our major finding is that the rs67153654 risk allele in FAM155 is significantly associated with diverticulitis 
after adjusting for cofactors, but not with diverticulosis. The data on the risk variant rs4662344 in ARHGAP15 was 
less consistent, it was borderline significantly associated with both diverticulosis and diverticulitis, but for confir-
mation additional larger studies are warranted. MAF of the analyzed SNPs was similar to previous data10,12,13,30. 
Even though the variants in ARHGAP15 and FAM155A initially discovered in the Icelandic/Danish GWAS10 
are at partially different genetic positions on the same genes compared to the variants identified in the following 
GWAS12,13, their LD indicates their common heritability. Therefore, an analysis using the SNPs initially identified 
in the Icelandic GWAS10, which applied weighted thresholds, is justified.
All of the analyzed SNPs are located in introns, supporting a molecular mechanism at the level of 
RNA-expression in the surrounding gene or LD to another, yet unidentified causal variant.
One of the major strengths of our study is the availability of clinical and endoscopic data and covariates, allow-
ing the exact separation of patients with uncomplicated diverticulosis from patients developing diverticulitis. 
Patients treated for diverticulitis as outpatients were also included in our analysis. Our study adds new insights 
into the susceptibility for diverticulitis, specifically attributing the association with the risk variant in FAM155A 
(protective effect) to diverticulitis, but not diverticulosis. Our study has certain limitations though, that have to 
be acknowledged. Due to the retrospective design of the study, we could not investigate the outcomes of divertic-
ulosis and diverticulitis, including DD-associated mortality. Even though a similar genetic background is shared 
between Germans and Lithuanians15 our results can not necessarily be transferred to non-Caucasians and have 
to be validated in other ethnicities ethnicity-specific analysis was not feasible due to sample size. Furthermore, 
several other variants associated to DD in the prior GWAS were not assessed in our analysis, and could also 
contribute significantly to the genetic risk to develop diverticulitis in patients with diverticulosis. Ultimately, 
the development of a genome-wide polygenic score31 should be strived for in both clincal entities diverticulosis 
and diverticulitis. The role of the risk variants in complicated DD could also not be explored, as our sample size 
for these additional subgroups was too small. Additionally, to the best of our knowledge only one study from 
2010 assessing the application of ICD codes for the discrimination of diverticulosis and diverticulitis is available. 
Therefore, confirmatory investigations are necessary. Further studies are also needed to understand which of 
the variants in FAM155A are the causal mutations. Furthermore, as the function of the involved genes is largely 
known, further elucidation of the molecular background of FAM155A deficiency in the pathogenesis of divertic-
ulitis is warranted.
Conclusions
Our results indicate, that the variant in FAM155A is associated with diverticulitis, but not diverticulosis in 
Caucasians, whereas a risk variant in ARHGAP15 might be associated with both diverticulosis and diverticulitis. 
Our results contribute to the assessment of these genetic variants identified in GWAS in the predisposition to the 
development of diverticulitis in patients with diverticulosis.
Data availability
The datasets generated during and/or analyzed during the current study are available on request as permitted by 
data protection laws and patients consent.
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